KIR2DL1 and malaria: A previous study reported decreased expression of KIR2DL1/S1 inhibitory/activation marker and increased expression of KIR3DL1 in children exposed to malaria and eBL patients relative to healthy children9, hence future studies will need to assess the mechanistic implications of KIR proteins and gene expression profiles in eBL pathogenesis.